Loading clinical trials...
Loading clinical trials...
Prevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves' Disease
The study will try to answer the question of whether early treatment with levothyroxine at 4 weeks after radioactive iodine for Graves'disease will prevent overt hypothyroidism (low thyroid hormone levels).
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
September 1, 2013
Primary Completion Date
April 1, 2017
Completion Date
April 1, 2017
Last Updated
October 29, 2019
61
ACTUAL participants
Levothyroxine
DRUG
Placebo
OTHER
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02373995